Patent · US Active

Dispersible formulations of N-((R)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

US11571402B2 · kind B2 · utility

5Cited by

5References

11Claims

0Family size

Assignee

SpringWorks Therapeutics, Inc. · US

Inventors

Kristin Patterson · Stamford, US
Jiping Liu · Tuji, CN

Key dates

Filing date	Feb 17, 2021
Grant date	Feb 7, 2023
Priority date	—
Expiry date	Feb 17, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2072
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to dispersible pharmaceutical compositions comprising N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, a pharmaceutically acceptable carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.